← Leaderboards
Alexandria Young
University Of Illinois At Chicago
$184,104
Attributed
$184,104
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50.5K · FY2017–20$100K$75K$50K$25K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$184,104 · 1
By mechanism
F30$184,104 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Joanna E Burdette$8,615,329
- Geula Gibori$4,214,509
- Jonathan Coppeta$1,986,049
- Ji-Yong Julie Kim$19,641,882
- Eileen Martin$8,190,285
Others in their field
Other Emerging Leaders on “Anticancer Research”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$238,320,768
- Leonard Freedman · Leidos Biomedical Research, Inc.$161,112,755
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$39,889,328
- Dwayne Forquer · Leidos Biomedical Research, Inc.$29,410,041
- Leonard Freedmand · Leidos Biomedical Research, Inc.$22,652,885
Research focus
Anticancer ResearchApoptosisApoptoticBenchmarkingCancer Cell LineCancer InitiationCancerousCell Culture TechniquesCell ProliferationCellsChemokineChemotherapyCollaborationsCorpus LuteumDab2 GeneDevicesDiagnosisDisease ModelDistant MetastasisDna DamageDna MappingDrug CompoundingDrug DevelopmentEarly Diagnosis
Grant awards (4)
FemKube, the human female reproductive tract-on-a-chip, as a platform for studying high grade serous ovarian cancer and developing novel cancer chemotherapeutics$50,520
F30 · FY2020 · CA · contact PI
FemKube, the human female reproductive tract-on-a-chip, as a platform for studying high grade serous ovarian cancer and developing novel cancer chemotherapeutics$45,016
F30 · FY2019 · CA · contact PI
FemKube, the human female reproductive tract-on-a-chip, as a platform for studying high grade serous ovarian cancer and developing novel cancer chemotherapeutics$44,524
F30 · FY2018 · CA · contact PI
FemKube, the human female reproductive tract-on-a-chip, as a platform for studying high grade serous ovarian cancer and developing novel cancer chemotherapeutics$44,044
F30 · FY2017 · CA · contact PI